GlycoMimetics, Inc. (GLYC)
USD 0.22
(-4.8%)
USD 0.22
(-4.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -34.87 Million | -46.45 Million | -57.48 Million | -39.24 Million | -51.98 Million | -43.33 Million |
| Net Income | -36.89 Million | -46.68 Million | -63.42 Million | -51.02 Million | -57.89 Million | -48.27 Million |
| Depreciation & Amortization | 153.3 Thousand | 207.14 Thousand | 264.6 Thousand | 270.75 Thousand | 279.23 Thousand | 275.12 Thousand |
| Deferred income taxes | 102.07 Million | - | 2174.00 | - | - | - |
| Stock-based compensation | 3.56 Million | 3.85 Million | 6.08 Million | 6.9 Million | 6.21 Million | 4.58 Million |
| Change in working capital | -2.55 Million | -4.66 Million | -1.16 Million | 3.93 Million | -1.2 Million | 80.11 Thousand |
| Other non-cash items | -101.21 Million | 828.5 Thousand | 749.03 Thousand | 680.84 Thousand | 620.06 Thousand | 168.00 |
| Investing Cash Flow | -21.39 Thousand | -84.19 Thousand | -14.94 Thousand | -68.5 Thousand | -144.92 Thousand | -125.61 Thousand |
| Investments in PPE | -21.39 Thousand | -84.19 Thousand | -14.94 Thousand | -68.5 Thousand | -144.92 Thousand | -125.61 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -126 Thousand |
| Financing Cash Flow | 28.82 Million | 4.15 Million | 10.72 Million | 18.14 Million | 412.91 Thousand | 129.44 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 28.82 Million | 4.15 Million | 10.69 Million | 17.82 Million | 412.91 Thousand | 128.42 Million |
| Other Financing Activities | 28.78 Billion | 4.15 Million | 25.02 Thousand | 319.29 Thousand | 412.91 Thousand | 1.02 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -102.07 Thousand | -1.13 Million | 17.67 Thousand | 654.27 Thousand | -1.22 Million | 16.48 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.45 Million | -3.52 Million | -1.18 Million | 3.27 Million | 21.29 Thousand | 63.62 Thousand |
| Cash at beginning of period | 47.87 Million | 90.25 Million | 137.03 Million | 158.2 Million | 209.91 Million | 123.92 Million |
| Cash at end of period | 41.79 Million | 47.87 Million | 90.25 Million | 137.03 Million | 158.2 Million | 209.91 Million |
| Capital Expenditure | -21.39 Thousand | -84.19 Thousand | -14.94 Thousand | -68.5 Thousand | -144.92 Thousand | -125.61 Thousand |
| Effect of forex changes on cash | -6.07 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | -6.07 Million | -42.38 Million | -46.78 Million | -21.16 Million | -51.71 Million | 85.99 Million |
| Free Cash Flow | -34.9 Million | -46.54 Million | -57.5 Million | -39.31 Million | -52.12 Million | -43.45 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.09 Million | -10.73 Million | -36.89 Million | -9.07 Million | -9.2 Million | -8.25 Million |
| Depreciation & Amortization | 12.42 Thousand | 14.62 Thousand | 153.3 Thousand | 23.29 Thousand | 42.74 Thousand | 43.41 Thousand |
| Deferred income taxes | - | - | 102.07 Million | -452.73 Thousand | - | - |
| Stock-based compensation | 1.24 Million | 1.22 Million | 3.56 Million | 944.37 Thousand | 887.83 Thousand | 858.08 Thousand |
| Change in working capital | -231.13 Thousand | -1.18 Million | -2.55 Million | 299.86 Thousand | -638.44 Thousand | 160.1 Thousand |
| Other non-cash items | 1.25 Million | 1.53 Million | -101.21 Million | 649.2 Thousand | 227.19 Thousand | 222.44 Thousand |
| Investing Cash Flow | -2533.00 | -7439.00 | -21.39 Thousand | -801.00 | -7866.00 | -10.53 Thousand |
| Investments in PPE | -2533.00 | -7439.00 | -21.39 Thousand | -801.00 | -7866.00 | -10.53 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 500.00 | 4898.00 | 28.82 Million | 999.00 | 61.61 Thousand | 20.11 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 500.00 | 4898.00 | 28.82 Million | 999.00 | 61.61 Thousand | 20.11 Thousand |
| Other Financing Activities | 500.00 | 4898.00 | 28.78 Billion | 999.00 | 61.61 Thousand | 20.11 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 195.22 Thousand | -112.58 Thousand | -102.07 Thousand | 538.23 Thousand | 88.39 Thousand | -238.66 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -426.36 Thousand | -1.07 Million | -2.45 Million | -238.36 Thousand | -726.84 Thousand | 398.76 Thousand |
| Cash at beginning of period | 31.28 Million | 41.79 Million | 47.87 Million | 49.4 Million | 58.03 Million | 65 Million |
| Cash at end of period | 22.38 Million | 31.28 Million | 41.79 Million | 41.79 Million | 49.4 Million | 58.03 Million |
| Capital Expenditure | -2533.00 | -7439.00 | -21.39 Thousand | -801.00 | -7866.00 | -10.53 Thousand |
| Effect of forex changes on cash | - | - | -6.07 Billion | -929.84 Million | 922.6 Million | 7.23 Million |
| Net cash flow / Change in cash | -8.89 Million | -10.51 Million | -6.07 Million | -7.61 Million | -8.62 Million | -6.96 Million |
| Free Cash Flow | -8.89 Million | -10.51 Million | -34.9 Million | -7.61 Million | -8.69 Million | -6.98 Million |
TMIP
BITE
GLHRL
MVV1
M44U
ADVPETR-B